Alison Kerans
Psychiatric/Mental Health · Canton, ILNPI 1811618150
Payments from drug & device makers
Across 142 payments — averaging $19.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$940
- Otsuka America Pharmaceutical, Inc.$498
- Vanda Pharmaceuticals Inc.$300
- Neurocrine Biosciences, Inc.$185
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$163
- Almatica Pharma LLC$137
- plus $560 from 14 others
What the payments were for
- Food & beverage$2,771100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,783 in reported general payments places this provider in the 85th percentile of 922 psychiatric/mental health providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 25 | $90,708 |
| Lurasidone Hcl | 63 | $40,620 |
| CaplytaLumateperone Tosylate | 11 | $21,051 |
| Aripiprazole | 111 | $5,982 |
| Chlorpromazine Hcl | 21 | $4,265 |
| Clozapine | 39 | $3,092 |
| Lamotrigine OdtLamotrigine | 13 | $1,372 |
| Paliperidone ErPaliperidone | 14 | $1,213 |
| Olanzapine | 55 | $1,034 |
| Hydroxyzine Hcl | 42 | $998 |
| Quetiapine Fumarate | 91 | $956 |
| Clonazepam | 106 | $673 |
| Lamotrigine | 98 | $593 |
| Buspirone Hcl | 61 | $574 |
| Citalopram HbrCitalopram Hydrobromide | 85 | $569 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $163 | $21,05111 claims |
| Almatica Pharma LLCSertraline Hcl | $137 | $18358 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 922 psychiatric/mental health providers in Illinois.
Other psychiatric/mental health in Canton
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$162K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.